I guess from the info Tony listed it shows Tat is being used in research. I guess what pyc is trying to do at least to some degree is generate an interest from those using tat currently in their research and get them to switch to our fpp. I guess the only issue may be they use tat for free like we used omomyc. Will they be willing to pay for fpp instead. Maybe so if 160 times more effective??
Ann: Fourfold Delivery Improvement in a New Lead Candidate, page-45
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $336.1K | 265.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 444 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 59836 | 2 |
View Market Depth
| Last trade - 15.47pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |